- Respiratory disease models/ efficacy studies
- Full service histopathology labs
- Molecular services
A specialized CRO devoted to your inhalation drug development success
Inhalation Sciences is a focused CRO devoted to your inhalation drug development success, offering preclinical research and development services to successfully develop orally inhaled and intra-nasal drug products. Developing respiratory therapies presents specific challenges that Inhalation Sciences has addressed with proprietary and unique approaches to de-risk clinical trials.
Read more about Inhalation SciencesInhalation Research Services
endif; ?>1Efficacy studies/
Disease models
2Formulation
Small molecules
Biologics
- Excipient selection
- Characterization of attributes
- Formulation development
- Process development
- Analytical testing
- Stability studies
3PK studies
In vitro, ex vivo,
in vivo
- Aerosol characterization
- In vivo PK studies
- Ex vivo Isolated Perfused Lung studies
- In vitro dissolution tests – DissolvIt
- In vitro cell permeability studies
4Toxicology studies
GLP and non GLP
- General toxicology
- Acute inhalation toxicology
- Safety pharmacology
- Reprotoxicity
5Drug-device product
development/ Device
selection/ CMC data
- Combination product development
- Process development
- Device selection
- Scale up support
- Generation of all CMC data required
Instruments
PreciseInhale®, DissolvIt®, XposeALI®
- Preciselnhale aerosol generator
- In vivo modules
- DissolvIt dissolution method
- XposeALI cell exposure at Air- Liquid Interface
We’re the Inhalation Scientists.
Try us!
Our founder and CSO Per Gerde is a recognized world authority and Associate Professor of Inhalation Toxicology, Institute of Environmental Medicine, Karolinska Institutet. Our multi-disciplinary team has extensive Contract Research experience — which has fed directly into the Inhalation Research Services portfolio.
BREATHE NEW LIFE INTO INHALATION R&D.
Book a meeting for an overview of how our research services can support your drug development
Talk to us and find out exactly how our Inhalation Research Service portfolio can successfully support your preclinical orally inhaled or intra-nasal drug product development.